Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

2.33
-0.5700-19.66%
Post-market: 2.31-0.0180-0.77%19:59 EDT
Volume:8.15M
Turnover:18.48M
Market Cap:194.34M
PE:-1.66
High:2.41
Open:2.38
Low:2.12
Close:2.90
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:49.56M
Volume Ratio:15.51
T/O Rate:16.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:16.99
PE(LYR):-1.82

Loading ...

Pyxis Oncology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Pyxis Oncology Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 13

Pyxis Oncology Posts Corporate Deck Spotlighting MICVO Extracellular-Targeting ADC in Head-and-Neck Cancer

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate

Benzinga Earnings
·
Aug 13

Pyxis Oncology Q2 Net Income USD -25.346 Million

Reuters
·
Aug 13

Pyxis Oncology Q2 Operating Expenses USD 25.99 Million

THOMSON REUTERS
·
Aug 13

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
Aug 13

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
Aug 13

NASDAQ Trade Halt Volatility Trading Pause at 12:27 Pm

Reuters
·
Aug 12

Pyxis Oncology Inc Expected to Post a Loss of 35 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Pyxis Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Aug 03

Wells Fargo Initiates Pyxis Oncology at Overweight With $12 Price Target

MT Newswires Live
·
Aug 03

Pyxis Oncology Files Form 3 Beneficial Ownership Statement for Gordonmd Global Investments LP

Reuters
·
Jul 11

Analysts’ Top Healthcare Picks: Pyxis Oncology (PYXS), Pfizer (PFE)

TIPRANKS
·
Jul 03

Pyxis Oncology Director Jakob Dupont Disposes of 35,000 Common Shares Worth $107,100

Reuters
·
Jul 03

Pyxis Oncology Prices Unregistered Private Placement at USD 50 Million

Reuters
·
Jul 03

Pyxis Oncology is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jul 02

Pyxis Oncology Posts Corporate Deck Outlining Strategy to Build Differentiated Antibody-drug Conjugate Company Around MICVO Program in Head and Neck Cancer

Reuters
·
Jun 30

Pyxis Oncology announces up to $114M private placement

TIPRANKS
·
Jun 30